Akademik Veri Yönetim Sistemi
8th Intercontınental Emergency Medıcıne Congress., Antalya, Türkiye, 14 - 17 Ekim 2021, ss.38
INTRODUCTION
COVID19 was defined as a global pandemic by the World Health Organization in early March 2020. COVID19 is a single-stranded RNA virus. While most human coronaviruses cause mild respiratory illness, other deadly coronavirus infections, namely severe acute respiratory syndrome coronavirus (SARS-CoV1) and Middle East respiratory syndrome coronavirus (MERSCoV)1 have emerged in the past two decades. The new SARS-CoV2 primarily affects the lungs, but fatally affects many other organs and systems, particularly the renal, cardiological, hematological and nervous systems. Neurological manifestations of SARS-CoV2 occur in three categories. These; such as central nervous system (dizziness, headache, cerebrovascular disease, seizure,altered consciousness), peripheral nervous system (anosmia, taste loss, visual impairment, neuropathic pain, etc.) and skeletal muscle injury. In an observational study from Wuhan, 36.4% of COVID-19 patients presenting with neurological symptoms, the most common symptom was dizziness (16.8%), followed by headache (13.1%). In another prospective analysis performed outside of Wuhan, headache, the most common neurological symptom overall, was present in 8% of all patients.
Viruses that infect the respiratory tract can often cause neurological symptoms, and headaches are among the most common (along with encephalopathy, seizures, and encephalitis). In 2009, the most frequently reported neurological symptom of the H1N1 pandemic in a retrospective study was headache. In this study, we aimed to analyze the patients with headache symptoms who applied to the emergency department.
MATERIAL AND METHOD
In this study, we retrospectively evaluated the complaints of headache in patients in the first six months of 2020 and 2021 during the COVID-19 epidemic. Patients diagnosed with headache were scanned from the hospital data system. It was evaluated whether the patients had retrospective COVID-19 disease. It is divided into two groups as patients who have had COVID-19 disease and patients who have not. Sociodemographic characteristics of the patients were examined. The data were analyzed in SPSS 20.0 and given as frequency and percentage.
RESULT
A total of 7779 patients applied with headache in the whole year of 2020, and 3411 (43.8%) of these applicants were male and 4368 (56.2%) were female, with a mean age of 51. The total number of applications with headache in the first 6 months of 2021 was 8332, 3439 (41.3%) of these applications were male and 4893 (58.7%) were female patients, with a mean age of 54. Of the applicants, 45% of the men and 47% of the women had corona, and they concluded that their pain continued unabated in the ongoing period.
CONCLUSIONS
The total number of applicants with headaches in the whole year of 2020 has been numerically captured in the first six months of 2021. This shows that with the increasing number of patients with COVID19, there is a tendency to increase in neurological complaints in patients.